One of the main objectives of the Saint Louis University Liver Center is to apply new technologies discovered by basic science and clinical research to the medical care of patients with liver disease.
Expertise in the field of liver disease research by the renowned SLU Liver Center physician investigators, is the catalyst which attracts pharmaceutical industries to desire that Saint Louis University participate in their clinical trials. Because of this, it’s important to note that the Division of Gastroenterology and Hepatology alone, does over 1/3 of all clinical trials that are conducted at Saint Louis University. The SLU Liver Center participates in many multi-center studies of new medications to see if they might be effective for the treatment of hepatitis B, hepatitis C, nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC) and other forms of liver disease.
Conducting these trials in a safe and efficient manner is critical to their success. Maintaining the integrity of clinical trials and the safety of enrolled patients is paramount and there isn’t a better team of individuals to do this than the clinical trials research staff in the GI and Hepatology Clinical Trial Units at SLU.
If you have liver disease and would like to know if the Liver Center currently has a trial that you might be interested in hearing more about, call the clinical trials unit at 314-977-9400. There is no obligation by calling.